Analysts think BBLG stock price could increase by 1143%
Jun 14, 2024, 6:29 AM
-20.94%
What does BBLG do
Bone Biologics Corp, headquartered in Burlington, Massachusetts with 2 employees, specializes in bone regeneration technologies for spinal fusion using NELL-1, a recombinant human protein. Since its IPO in 2015, the company focuses on developing NELL-1/DBM devices for spine implants, trauma, and osteoporosis applications.
3 analysts think BBLG stock price will increase by 1143.13%. The current median analyst target is $19.89 compared to a current stock price of $1.60. The lowest analysts target is $19.70 and the highest analyst target is $20.48.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.